How do I buy AbCellera Biologics (ABCL) stock?

You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.View our list of the best stock brokerages

Who are AbCellera Biologics (ABCL) competitors?

Other companies in AbCellera Biologics’s space includes: 10x Genomics Inc (NASDAQ:TXG), BioLife Solutions Inc (NASDAQ:BLFS), Sotera Health Co (NASDAQ:SHC), Quanterix Corp (NASDAQ:QTRX) and Cytek Biosciences Inc (NASDAQ:CTKB).

What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?

AbCellera Biologics has a consensus price target of $16.88.

What is the current price for AbCellera Biologics (ABCL)?

The stock price for AbCellera Biologics (NASDAQ: ABCL) is $4.25 last updated January 23, 2026 at 7:14 PM EST.

Does AbCellera Biologics (ABCL) pay a dividend?

There are no upcoming dividends for AbCellera Biologics.

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

AbCellera Biologics does not have any upcoming earnings scheduled.

Is AbCellera Biologics (ABCL) going to split?

There is no upcoming split for AbCellera Biologics.

What sector and industry does AbCellera Biologics (ABCL) operate in?

AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

AbCellera Biologics (ABCL) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Life Sciences Tools & Services

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and...

Comments